OGC
APLS icon

One68 Global Capital’s Apellis Pharmaceuticals APLS Stock Holding History

One68 Global Capital’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-55,347
Closed -$2.23M – 58
2026
Q1 		$2.23M Buy
+55,347
New +$1.19M 7.21% 4

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

One68 Global Capital's APLS Position: Q2 2026 in Review

One68 Global Capital sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 55,347 shares — an estimated $2.23M sold.

One68 Global Capital first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.23M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • One68 Global Capital reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • One68 Global Capital sold 55,347 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.23M.
  • One68 Global Capital first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • One68 Global Capital's Apellis Pharmaceuticals position peaked at $2.23M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on One68 Global Capital's 13F filing for Q2 2026, filed 14 Aug 2026.